Evidence map›Paper›PMID 42396028›Full record

ArticleACS omega2026

Sulfa-Drug-Functionalized Schiff Bases in the Selective Detection of Erythromycin.

Satyendra Verma, Jubaraj B Baruah

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Satyendra VermaDepartment of Chemistry, Indian Institute of Technology Guwahati, Guwahati, Assam 781 039, India.
Jubaraj B BaruahDepartment of Chemistry, Indian Institute of Technology Guwahati, Guwahati, Assam 781 039, India.ORCID https://orcid.org/0000-0003-3371-7529

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, selective detection of erythromycin in aqueous solution was achieved by using sulfa-drug-based Schiff bases as fluorescent probes. The detections were performed by simple imines synthesized in a single-step condensation of sulfa drugs, namely sulfadiazine or sulfamethazine, with 4-dimethylamino cinnamaldehyde. The portions from the sulfa drugs present in each probe had played the key role in guiding the selectivity in fluorescence detection by controlling the twisted intramolecular charge transfer (TICT) emission. Theoretical studies have suggested the role of the O-H···π interaction in the selective detections. A cocrystal of sulfadiazine with cinnamaldehyde was characterized during the course of this study; it was not useful for the detection of erythromycin. It was also found that the corresponding Schiff base of aniline and 4-dimethylamino cinnamaldehyde was not selective to make a distinction of erythromycin from other drugs by fluorescence changes. The detection limit for the selective detections of the Schiff base probe of the respective Schiff bases, namely, with sulfadiazine, was 134.5 nM, and with sulfamethazine, it was 180 nM. These limits were comparable in sensitivity to the nanomaterials-based detections reported in the literature. The advantages of the present systems are an easy method of preparation, aqueous stability, the use of benign commercial drugs as probe precursors, and performance at neutral conditions in aqueous medium.

Identifiers

PMID42396028
PMCPMC13325382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.